financetom
Business
financetom
/
Business
/
3iQ Launches an XRP Digital Asset ETF
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
3iQ Launches an XRP Digital Asset ETF
Jun 18, 2025 9:37 AM

12:19 PM EDT, 06/18/2025 (MT Newswires) -- 3iQ (XRPQ.TO), a company providing digital asset investment solutions, on Wednesday announced the launch of the 3iQ XRP ETF (XRPQ.TO, XRPQ.U), opening trade on the Toronto Stock Exchange..

According to a company statement, XRPQ is "one of the first exchange-traded fund (ETF) in North America to provide investors with exposure to XRP," the third-largest digital asset by market capitalization.

XRP is the native digital asset of the XRP Ledger, an open-source blockchain designed for "high-speed, low-cost payments across borders." Since January 2015, XRP's price has climbed from $0.02 to over $2.19, an increase of more than 10,800%

"XRP has demonstrated significant growth potential over the past decade, and this groundbreaking strategy offers Canadian and qualified global investors a transparent, low-cost and tax-efficient way to securely access that opportunity," said President and CEO Pascal St-Jean. "Ripple Labs' investment support reflects our shared leadership in advancing the digital asset space."

The company's shares were last seen down $0.11 to $13.4& on the Toronto Stock Exchange.

Price: 13.47, Change: -0.11, Percent Change: -0.81

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GeneDx Says FDA Granted Fast-Track Designation for Exome, Genome Tests; Shares Up Pre-Bell
GeneDx Says FDA Granted Fast-Track Designation for Exome, Genome Tests; Shares Up Pre-Bell
Oct 20, 2025
08:53 AM EDT, 10/20/2025 (MT Newswires) -- GeneDx Holdings ( WGS ) said Monday that the US Food and Drug Administration granted breakthrough device designation for its ExomeDx and GenomeDx genetic tests. The company said the designation applies to its whole genome and exome testing used to identify genetic causes of life-threatening diseases and disorders. GeneDx ( WGS ) said...
Sector Update: Consumer
Sector Update: Consumer
Oct 20, 2025
08:54 AM EDT, 10/20/2025 (MT Newswires) -- Consumer stocks were steady premarket Monday, with the Consumer Discretionary Select Sector SPDR Fund (XLY) inactive and the Consumer Staples Select Sector SPDR Fund (XLP) up a slight 0.1%. Stellantis ( STLA ) Chief Executive Officer Antonio Filosa is to meet with Italian labor unions Monday, as the carmaker has paused production at...
Rapt Therapeutics, Shanghai Jeyou Say Potential Autoimmune Therapy Effective at Longer Dose Intervals
Rapt Therapeutics, Shanghai Jeyou Say Potential Autoimmune Therapy Effective at Longer Dose Intervals
Oct 20, 2025
08:56 AM EDT, 10/20/2025 (MT Newswires) -- Rapt Therapeutics ( RAPT ) and Shanghai Jeyou Pharmaceutical said Monday that their jointly developed therapy RPT904 dosed at eight-week or 12-week intervals in a mid-stage trial was about as effective and safe as omalizumab dosed every four weeks. The companies said RPT904 was well tolerated with no serious adverse results related to...
AbbVie's Rinvoq shows superiority over Humira in head-to-head arthritis study
AbbVie's Rinvoq shows superiority over Humira in head-to-head arthritis study
Oct 20, 2025
Oct 20 (Reuters) - AbbVie ( ABBV ) said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira in a head-to-head . AbbVie ( ABBV ) has been banking on its newer immunology drugs Skyrizi and Rinvoq to counter the drop in Humira sales due to a loss of exclusivity and competition from cheaper...
Copyright 2023-2026 - www.financetom.com All Rights Reserved